Matthew Strobeck Insider Trading $AXK Accelerate Diagnostics, Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew Strobeck.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew Strobeck. Matthew Strobeck is Director in Accelerate Diagnostics, Inc ($AXK) and Director in QUIDEL CORP /DE/ ($QDEL) and Director in METABOLIX, INC. ($MBLX) and in BIODESIX INC ($BDSX) and Director in BIODESIX INC ($BDSX).
Matthew Strobeck in Accelerate Diagnostics, Inc
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Matthew Strobeck: Director
Holdings: 187,297 shares
Latest Transaction: May 24 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Matthew Strobeck in Accelerate Diagnostics, Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AXK, BDSX, QDEL, MBLX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2021 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Option Exercise | A | 7.68 | 35,168 | 270,090 | 35,168 | |
| Apr 13 2021 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Grant | A | 7.68 | 19,531 | 149,998 | 187,297 | 167.8 K to 187.3 K (+11.64 %) |
| Feb 24 2021 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Grant | A | 7.68 | 19,531 | 149,998 | 167,766 | 148.2 K to 167.8 K (+13.18 %) |
| Apr 03 2020 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Option Exercise | A | 8.33 | 13,779 | 114,779 | 13,779 | |
| Mar 27 2020 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Option Exercise | A | 21.02 | 12,290 | 258,336 | 12,290 | |
| Mar 20 2020 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Gift | G | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Mar 20 2020 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Gift | G | 0.00 | 20,000 | 0 | 2,025,560 | 2 M to 2 M (-0.98 %) |
| Mar 20 2020 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Buy | P | 7.11 | 10,000 | 71,100 | 148,235 | 138.2 K to 148.2 K (+7.23 %) |
| Apr 03 2018 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Option Exercise | A | 22.85 | 9,476 | 216,527 | 9,476 | |
| Apr 04 2017 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Option Exercise | A | 24.20 | 11,721 | 283,648 | 11,721 | |
| Jan 10 2017 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Buy | P | 19.00 | 8,000 | 152,000 | 138,235 | 130.2 K to 138.2 K (+6.14 %) |
| Apr 01 2016 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Option Exercise | A | 14.37 | 8,181 | 117,561 | 74,937 | |
| Feb 10 2016 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Buy | P | 11.52 | 20,000 | 230,400 | 130,235 | 110.2 K to 130.2 K (+18.14 %) |
| Dec 17 2015 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Buy | P | 17.00 | 88,235 | 1,499,995 | 110,235 | 22 K to 110.2 K (+401.07 %) |
| Apr 06 2015 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Option Exercise | A | 22.92 | 7,658 | 175,521 | 66,756 | |
| Mar 23 2015 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Buy | P | 22.04 | 2,000 | 44,080 | 22,000 | 20 K to 22 K (+10.00 %) |
Page: 1